A Portable Thoracic Impedance Device for Detecting Pulmonary Congestion in Heart Failure Patients
Recruiting now
Conditions studied: Heart Failure
In brief
This study investigates a portable thoracic bioimpedance tomography (TBIT) device designed to detect early lung congestion in heart failure patients. The main goal is to evaluate how well the device's measurements match those obtained from lung ultrasound and other imaging techniques. By detecting lung fluid build-up before symptoms worsen, this device could help manage heart failure more effectively outside of hospital settings, potentially improving patient care and reducing hospital admissions. Participants in the study are monitored using this device along with standard imaging methods, and data on heart failure symptoms are collected to understand the device\'s accuracy and usability.
Key facts
- Study ID
- NCT06604468
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
- People needed
- 30
- Starts
- 2025-09-01
- Expected to finish
- 2026-09-01
- Last updated by the study team
- 2025-10-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged 18 years or older.
- Diagnosed with heart failure, defined by the following criterion: hospitalization or an emergency visit for decompensated heart failure (pulmonary edema) within the last 12 months.
You may not qualify if…
- Pregnant women at the time of eligibility evaluation.
- Presence of an implanted electronic device in the thorax, such as a pacemaker or defibrillator.
- Inability to provide informed consent.
- Admission to intensive care or the coronary care unit.
Where it is running
- CHUM — Montreal, Quebec, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.